المؤلفون: Lexchin J; School of Health Policy and Management, York University, Toronto, ON, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada., Dong BM; School of Journalism and Communication, Carleton University, Ottawa, ON, Canada., Ramanathan A; School of Public Policy & Administration, Carleton University, Ottawa, ON, Canada., Gagnon MA; School of Public Policy & Administration, Carleton University, Ottawa, ON, Canada.

المصدر: International journal of health policy and management [Int J Health Policy Manag] 2024; Vol. 13, pp. 8239. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Kerman University of Medical Sciences Country of Publication: Iran NLM ID: 101619905 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2322-5939 (Electronic) Linking ISSN: 23225939 NLM ISO Abbreviation: Int J Health Policy Manag Subsets: MEDLINE

مواضيع طبية MeSH: Drug Industry*/economics , Clinical Trials, Phase IV as Topic*, Canada ; Humans ; Research Support as Topic/statistics & numerical data ; Registries

المؤلفون: Trailokya A; Head, Department of Medical Affairs, Indoco Remedies Limited, Mumbai, Maharashtra, India, Corresponding Author., Srivastava A; Consultant, Clinical Research and Drug Development, Ahmedabad, Gujarat, India., Mukaddam Q; Independent Pharma Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India., Chaudhry S; Director and Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India., Patel K; Head, Department of Medical and Health Technology, Lupin Limited, Mumbai, Maharashtra, India., Suryawanshi S; Director, Medical Services Emcure Pharmaceutical Ltd., Mumbai, Maharashtra, India., Naik M; Head, Department of Clinical Operations and Pharmacovigilance, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India.

المصدر: The Journal of the Association of Physicians of India [J Assoc Physicians India] 2024 Jan; Vol. 72 (1), pp. 85-87.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN: 0004-5772 (Print) Linking ISSN: 00045772 NLM ISO Abbreviation: J Assoc Physicians India Subsets: MEDLINE

مواضيع طبية MeSH: Product Surveillance, Postmarketing*/methods , Clinical Trials, Phase IV as Topic*, Humans

المؤلفون: Eustes AS; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Ahmed A; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Swamy J; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Patil G; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Jensen M; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Wilson KM; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Kudchadkar S; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Wahab A; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Perepu U; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Miller FJ Jr; Department of Internal Medicine, Vanderbilt University Medical Center and VA Medical Center, Nashville, Tennessee, USA., Lentz SR; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Dayal S; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA; Iowa City VA Healthcare System, Iowa City, Iowa, USA. Electronic address: sanjana-dayal@uiowa.edu.

المصدر: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Sep; Vol. 22 (9), pp. 2514-2530. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE

مواضيع طبية MeSH: Blood Platelets*/metabolism , COVID-19*/blood , COVID-19*/complications , Extracellular Vesicles*/metabolism , Histones*/blood , Platelet Activation* , Thrombosis*/blood , Thrombosis*/etiology, Adult ; Animals ; Female ; Humans ; Male ; Mice ; Middle Aged ; Blood Coagulation ; Case-Control Studies ; Citrullination ; Mice, Inbred C57BL ; Nucleosomes/metabolism ; Thrombin/metabolism ; Clinical Trials, Phase IV as Topic

المؤلفون: Shoamanesh A; McMaster University, Hamilton, ON, Canada., Sharma M; McMaster University, Hamilton, ON, Canada.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8).

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods , Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects, Humans ; Clinical Trials, Phase IV as Topic ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Research Design ; Rivaroxaban/adverse effects

المؤلفون: Kreutziger J; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at., Ulmer H; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at., Fries D; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 772-773.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods , Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects, Humans ; Clinical Trials, Phase IV as Topic ; Randomized Controlled Trials as Topic ; Rivaroxaban/adverse effects ; Multicenter Studies as Topic ; Research Design

المؤلفون: Wong ML; Lewis Katz School of Medicine at Temple University, Philadelphia, PA matthew.wong@tuhs.temple.edu.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 773.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods , Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects, Humans ; Clinical Trials, Phase IV as Topic ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Research Design ; Rivaroxaban/adverse effects

المؤلفون: Yates SG; University of Texas Southwestern Medical Center, Dallas, TX sean.yates@utsouthwestern.edu., Sarode R; University of Texas Southwestern Medical Center, Dallas, TX sean.yates@utsouthwestern.edu.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 773-774.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Cerebral Hemorrhage*/chemically induced , Cerebral Hemorrhage*/drug therapy , Factor Xa*/administration & dosage , Factor Xa*/adverse effects , Factor Xa Inhibitors*/adverse effects , Recombinant Proteins*/administration & dosage , Recombinant Proteins*/adverse effects , Anticoagulation Reversal*/adverse effects , Anticoagulation Reversal*/methods, Humans ; Rivaroxaban/adverse effects ; Multicenter Studies as Topic ; Clinical Trials, Phase IV as Topic ; Research Design ; Randomized Controlled Trials as Topic

المؤلفون: Stefan N; Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany. norbert.stefan@med.uni-tuebingen.de., Hartleb M; Department of Gastroenterology and Hepatology, Faculty of Medicine, Medical University of Silesia, Katowice, Poland., Popovic B; Sanofi, Frankfurt am Main, Germany., Varona R; Sanofi, Neuilly-sur-Seine, France.

المصدر: Trials [Trials] 2024 Jun 11; Vol. 25 (1), pp. 374. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Obesity*/complications , Multicenter Studies as Topic* , Randomized Controlled Trials as Topic* , Quality of Life* , Fatty Liver* , Hyperlipidemias*/complications, Humans ; Double-Blind Method ; Treatment Outcome ; Phospholipids ; Clinical Trials, Phase IV as Topic ; Male ; Adult ; Female ; Middle Aged

المؤلفون: Gao J; Clinical Center On TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, People's Republic of China., Gao M; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, People's Republic of China., Du J; Clinical Center On TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, People's Republic of China., Pang Y; Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, People's Republic of China., Mao G; Janssen Global Public Health, Janssen Research & Development, Titusville, NJ, USA., Lounis N; Janssen Pharmaceutica, Beerse, Belgium., Bakare N; Janssen Global Public Health, Janssen Research & Development, Titusville, NJ, USA., Jiang Y; Janssen China Research & Development, Shanghai, People's Republic of China., Zhan Y; Innovation Alliance On Tuberculosis Diagnosis and Treatment (Beijing) [IATB], Beijing, 101100, People's Republic of China., Liu Y; Clinical Center On TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, People's Republic of China. liuyuhong0516@126.com., Li L; Clinical Center On TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, People's Republic of China. liliang@tb123.org.

مؤلفون مشاركون: Trial Team

المصدر: Trials [Trials] 2024 Apr 01; Vol. 25 (1), pp. 227. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis*/drug therapy , Tuberculosis, Multidrug-Resistant*/diagnosis , Tuberculosis, Multidrug-Resistant*/drug therapy , Tuberculosis, Multidrug-Resistant*/microbiology, Adult ; Humans ; Antitubercular Agents ; Clinical Trials, Phase IV as Topic ; Diarylquinolines/adverse effects ; Randomized Controlled Trials as Topic

المؤلفون: Barthélémy P; Institut de Cancérologie Strasbourg Europe, 17 Rue Albert Calmette, Strasbourg, 67200, France., Dutailly P; Ipsen, 65 Quai Georges Gorse, Boulogne-Billancourt, 92100, France., Qvick B; Ipsen, Einsteinstraße 174, München, 81677, Germany., Perrot V; Ipsen, 65 Quai Georges Gorse, Boulogne-Billancourt, 92100, France., Verzoni E; Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, Milano, 20133, Italy.

المصدر: Future oncology (London, England) [Future Oncol] 2024 Apr; Vol. 20 (13), pp. 811-819. Date of Electronic Publication: 2023 Jul 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/pathology , Antineoplastic Agents*/therapeutic use , Kidney Neoplasms*/pathology , Anilides* , Pyridines*, Humans ; Nivolumab/therapeutic use ; Prospective Studies ; Quality of Life ; Clinical Trials, Phase IV as Topic